BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Background Rate Hemangiosarcoma Pages on BioPortfolio:

BioPortfolio - Hemangiosarcoma
Hemangiosarcoma - BioPortfolio - Indepth. ... allintext: cancer butoxyethanol | hemangiosarcoma and Arsenic | background rate hemangiosarcoma | . ...
http://www.bioportfolio.com/indepth/Hemangiosarcoma.html...

BioPortfolio - Hemangiosarcoma - InDepth
BACKGROUND: Human hemangiosarcoma (HSA) tends to have a poor prognosis;...15th ... The role of dose-rate on risk from internally-deposited radionuclides and
...
http://www.bioportfolio.com/indepth/Hemangiosarcoma.pdf...

Results from other life science and pharmaceutical sites:

Gene Expression Profiles of Sporadic Canine Hemangiosarcoma Are ...
We took advantage of the predicted true positive rate and identified additional genes ..... to modulation by a dog's genetic background in hemangiosarcoma. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680013/...

BioMed Central | Full text | Establishment of canine ...
Background. Hemangiosarcoma (HSA) is a malignant neoplasm that originates .... There were no significant changes in the growth rate through passages in all ...
http://www.biomedcentral.com/1471-2407/9/363...

Feline visceral hemangiosarcoma.
BACKGROUND: Feline visceral hemangiosarcoma (HSA) is an uncommon tumor, ... is poor because of severe clinical signs, anemia, and a high rate of metastasis.
...
http://www.ncbi.nlm.nih.gov/pubmed/18289302...

Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen ...
... with an enriched C57BL/6 genetic background were generated after six successive ... The survival rate was calculated by the CA-Cricket Graph III
method, ... Liver hemangiosarcoma developed at a higher penetrance (50%) than
either ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14...

Establishment of canine hemangiosarcoma xenograft models ...
14 Oct 2009 ... Background. Human hemangiosarcoma (HSA) tends to have a poor prognosis; ..... There were no significant changes in the growth rate through ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768746/...

Pentachlorophenol (CASRN 87-86-5) | IRIS | US EPA
Background information and explanations of the methods used to derive the ... At the 30 mg/kg/day level of treatment, a reduced rate of body weight gain and
..... To give preference to the data on hemangiosarcomas and because some male
...
http://www.epa.gov/IRIS/subst/0086.htm...

Comparative aspects and clinical outcomes of canine renal ...
BACKGROUND: Hemangiosarcoma (HSA) is a common solid tumor of the spleen, heart, ... with improved 1-year survival rates and longer median survival time ...
http://www.ncbi.nlm.nih.gov/pubmed/16955823...

1,2-Dichloroethane (CASRN 107-06-2) | IRIS | US EPA
Background information and explanations of the methods used to derive the values given in IRIS .... Because of the high mortality rate in the high-dose rats, ...
The incidence of hemangiosarcoma was significantly elevated in the treated ...
http://www.epa.gov/iris/subst/0149.htm...

Comparison of endothelial cell proliferation in normal liver and ...
The increased rate of spontaneous or PPAR agonist-induced hemangiosarcoma formation in mice may be related to the higher background endothelial cell ...
http://www.ncbi.nlm.nih.gov/pubmed/18098037...

NTP REPORT ON CARCINOGENS BACKGROUND DOCUMENT for/i-CHLORO -0 ...
SIR (Standard Incidence Rate) = actual bladder tumor incidence in 49 workers over an .... The incidence of hemangiosarcoma (originating in the fatty tissue
...
http://ntp.niehs.nih.gov/index.cfm?objectid=161F6BB7-F1F6-97...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.